Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 45 Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Belfast
Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Belfast
We have 45 Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Belfast
A PhD in Pharmacy gives you the chance to lead your own research project that will further our current understanding of pharmaceuticals. Whether you are researching medicines tailored to an ageing population, optimising existing drugs through changes in dosage, or looking at the causes of neurological and psychiatric diseases, you will be aiming to improve the lives of millions of people around the globe.
What’s it like to study a PhD in Pharmacy?
Doing a PhD in Pharmacy, you will become proficient in the skills necessary to contribute to a research portfolio which spans pharmacy practice, pharmaceutics, and drug discovery. You will spend time reading around your research area and gain inspiration for methods to improve your experimental work. Your main aim will be to exploit the current advances in pharmaceutical practices and biological sciences.
Some typical research topics in Pharmacy include:
- nanomedicine and biotherapeutics
- developing nanomaterials for drug delivery
- infection and antimicrobial resistance
- pharmacy practice
Typical Pharmacy PhD research projects take between three and four years to complete. During a standard PhD day, you will either be in the laboratory performing, preparing, or planning experiments, (if your project is laboratory based), researching pharmacy practice and policy, writing up sections of your thesis, and chatting to your colleagues and supervisor about your current and upcoming work.
To be awarded your PhD, you must submit a thesis of about 60,000 words and defend this during your viva exam.
PhD in Pharmacy entry requirements
The entry requirements for a typical PhD in Pharmacy usually involves a Bachelors and a Masters degree in a related subject. You will also need to submit a compelling research proposal detailing your study plans. You may also need some professional experience in Pharmacy, depending on the programme.
PhD in Pharmacy funding options
In the UK, PhDs in Pharmacy are funded by the Medical Research Council (MRC), which provides a tuition fee waiver and a living cost stipend. Depending on the programme, you may submit your own research proposal before being considered for funding or apply for a project that already has funding attached.
It is also possible to apply for a PhD loan to help with the costs of a doctorate in Pharmacy (although this cannot be combined with Research Council funding). Other options for financial support include university scholarships, graduate teaching assistantships and charities.
If you are considering a part-time PhD in Pharmacy, it may also be worth asking your employer if they are happy to sponsor you.
PhD in Pharmacy careers
On completion of your PhD, you may go into a research role at a university or pharmaceutical company, or you may find a career in regulatory affairs, the NHS (National Health Service) or scientific publishing, drug licensing or clinical trial research.
PhD saved successfully
Investigating the role of the microbiome in infection and health outcomes following renal transplantation
Many infections and disease states are closely linked to associated microbiomes, either of the patient themselves or the surrounding clinical environment. Read more
Investigating the role of USP17 in EMT
USP17 is over-expressed in a range of primary tumours (NSCLC, breast, colorectal, cervical, ovarian, osteosarcoma) and its depletion blocks the growth, and migration, of cells from all of these cancer types. Read more
Relationship between antibiotic therapy and development of antimicrobial resistance in patients with bronchiectasis and COPD
To decrease the risk of acute infective exacerbations or flare-ups of their condition, individuals with bronchiectasis and COPD are frequently prescribed long-term oral and inhaled antibiotics. Read more
Dissecting mechanism of drug responses to novel anti-cancer therapies
Repurposing drug screens with compounds that have already gained FDA approval can accelerate the identification of new therapies to treat an illness and in the cancer setting extend life or provide compassionate care. Read more
Digital design and advanced processing technologies for antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (GAFFI). Read more
Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis Airways
The attachment of Pseudomonas aeruginosa (PA) to the airway mucus in the lungs of people with cystic fibrosis (CF) represents an important step in airway colonization and the subsequent development of lung infection. Read more
Development of a multi-antigenic mRNA vaccine for Glioblastoma
Glioblastoma is an aggressive brain tumour with the median survival time of ~15 months and the 5 year survival rates for those over 50 at a mere 6% (American Cancer Society). Read more
Countering the proteinase-activated receptor 1 (PAR-1) pro-tumour phenotype using a novel nanotherapeutic approach
Proteinase-activated receptor 1 (PAR1) is a G-protein coupled receptor (GPCR) expressed on a number of cell types, and is activated by serine proteases such as thrombin, plasmin and activated protein C. Read more
Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis
Targeted therapies such as tamoxifen, fulvestrant and anastrozole have exhibited significant clinical success since being introduced as treatments for Estrogen Receptor positive (ER+) breast cancer patients. Read more
High throughput screening models for intracellular delivery of antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (. GAFFI. ). Read more
Investigating the clinical and molecular significance of the microbiome in breast cancer
Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more
Measurement of outcomes for medicines management interventions for people living with dementia in primary care
Medicines management is a complex process for people living with dementia (PLWD), who often have other comorbidities and are frequently prescribed multiple regular medicines. Read more
Mechanochemical synthesis of polymer-drug conjugates via reactive extrusion
Polymer–drug conjugate (PDCs) therapeutics are pharmacologically active macromolecular constructs comprising at least one therapeutic agent covalently bound to a polymeric carrier. Read more
Microneedle delivery systems for next-generation antibody therapeutics
Microneedle arrays are minimally-invasive devices that painlessly, and without drawing blood, penetrate the skin’s stratum corneum barrier. Read more
Multifunctional Biomaterials to Combat Infection and Modulate Inflammation
Implantable medical devices are commonplace in modern medicine (e.g. joint replacements, stents, artificial heart valves, etc.), and are of ever increasing interest in the field of regenerative medicine. Read more